Serum microRNA-155 as a potential biomarker to track disease in breast cancer
about
Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and preventionNew Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesAppraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-AnalysisInflamma-miRs in Aging and Breast Cancer: Are They Reliable Players?Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialExploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer PatientsMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerResponse biomarkers: re-envisioning the approach to tailoring drug therapy for cancerCirculating microRNAs: potential biomarkers for common malignanciesIncreased circulating microRNA-155 as a potential biomarker for breast cancer screening: a meta-analysis.microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersDysregulated microRNA expression in serum of non-vaccinated children with varicella.MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serumAbundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy.Computational prediction of disease microRNAs in domestic animalsAssociation between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysisCirculating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.Binding sites of miR-1273 family on the mRNA of target genes.Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Natural killer cells in patients with severe chronic fatigue syndrome.MicroRNA-155 hallmarks promising accuracy for the diagnosis of various carcinomas: results from a meta-analysis.MicroRNA (miRNA) in cancerOver-expression of miR-675 in formalin-fixed paraffin-embedded (FFPE) tissues of breast cancer patients.How interacting pathways are regulated by miRNAs in breast cancer subtypes.MicroRNAs as Biomarkers in Cancer.Novel combination of serum microRNA for detecting breast cancer in the early stage.Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes.Serum expression levels of microRNA-382-3p, -598-3p, -1246 and -184 in breast cancer patients.Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancerEvaluation of microRNA Expression in Patients with Herpes Zoster.Over-expression of miR-98 in FFPE tissues might serve as a valuable source for biomarker discovery in breast cancer patients.Circulating nucleic acids as biomarkers in breast cancer.microRNAs: a new class of breast cancer biomarkers.The validity of circulating microRNAs in oncology: five years of challenges and contradictions.Crucial considerations for pipelines to validate circulating biomarkers for breast cancer.
P2860
Q26742027-C349C515-EABE-4907-ACF7-70F1201963B8Q26748881-55E2A076-EEAD-459B-9B94-956BEDD9A0F4Q26772056-9BB43652-9BC4-463E-A4CF-9B59CFB74F3FQ26772219-1C081D2D-05AB-4DB3-8045-E4400142ABD5Q26782613-7CEAA9CD-4625-43C0-A414-3326B53A6A8FQ26796590-B7C5A43A-6692-43A5-9BEB-41959083252BQ26801108-58621BDA-C4C9-4FF0-A451-893FA2EDD157Q28074295-FB780DA5-DE65-4304-8701-9BE856619FC5Q28081347-9C6FFD58-3153-4736-BCE5-B9E829B31C55Q31161472-775D6069-37A5-41C7-A051-928E6834BB04Q33576814-4C2EA8DE-DEF8-424E-89CD-DC4730576CFAQ33584804-925B654E-9A4A-4549-9B6C-FFDC18558797Q33585094-E18EE92D-A4E9-47B2-815D-A3FB4D6C5317Q33824699-5AE85772-A003-411D-BC0D-B60C2726752EQ33844289-8420CAB7-21F8-4BC6-97FB-75BC72BF2122Q33881021-9E13BD76-E3A3-41C4-8D56-E72156362024Q34029232-A393BC6A-1C40-4653-BAD8-4C7F740261FDQ34064171-EBBDC175-9E68-4C45-B501-AD988D6149E7Q34066078-A1364515-FD6B-4C02-91A5-12D1BD9AA371Q34162122-510A9D54-A12B-40C3-A1CF-03AEBD79CE6BQ34221705-DA07A445-8C21-4A21-AD45-89C983819D72Q34764211-E0B82E12-313A-4CDA-81CB-28BD052418E6Q35203556-A4F25130-2D4C-4D0A-9DDE-80CDCF03D65DQ35309120-937E8FF7-F4EA-4868-A4CE-01403D7D61BBQ35415884-2DAE0CD5-EE72-4E0E-997C-1F4C12D806F9Q35583538-D2DCF4EB-5777-45A7-BBA5-071939E1A8CFQ36046557-7D27C487-B8F2-4C27-8AA4-CC38074D62E0Q36276533-F5A7AA38-753F-483C-9910-B13DC7F27283Q36335261-85B93D0F-A2D0-40A7-9522-B25A6756FA48Q36746303-6B97582F-F557-41EA-A93A-222429EF889AQ36846957-4858E9A5-4AF7-47AD-9CB0-31B0D1C5DAFFQ37000986-FB36FE6E-7E14-42FD-BBAE-73DE2A341315Q37074134-CB90F3FC-170B-4D73-BD11-68709E128198Q37349506-EF983979-3776-475F-B3F4-D03EEDA345C8Q37539287-07A2DF88-7E6B-4A8D-8D19-CB1CE82617E2Q37676792-895730A2-DE04-40FF-8985-BCC67F152903Q37690204-C941F5CB-3220-4E8C-9BA9-B12B3483ADE4Q38197675-C693889F-E6D0-4829-A345-189DBF1169EAQ38198366-0DEC3D1B-4A63-4E07-83C9-7FCD47796790Q38665032-F69B1128-D127-4465-BA00-116D5447FA24
P2860
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@ast
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@en
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@nl
type
label
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@ast
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@en
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@nl
prefLabel
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@ast
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@en
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@nl
P2093
P2860
P1433
P1476
Serum microRNA-155 as a potential biomarker to track disease in breast cancer
@en
P2093
Guigao Lin
Jinming Li
Minjie Wang
Shipeng Sun
Xuexiang Li
P2860
P304
P356
10.1371/JOURNAL.PONE.0047003
P407
P577
2012-10-10T00:00:00Z